LLY Eli Lilly and Company
As of 11:25:00 AM ET
Loading chart…
- Open
- $1,403.08
- Previous close
- $1,417.54
- Day range
- 1,387.44 – 1,412.05
- 52-week range
- 850.51 – 1,449.68
- Volume
- 117.6K
- Avg volume (3M)
- 2.5M
- Market cap
- $1.3T
- P/E (TTM)
- 47.58
- EPS (TTM)
- $29.79
- Beta
- —
- Dividend yield
- 0.47%
- Next earnings
- Feb 3, 2027(estimated from past report dates; not yet confirmed by the company)
- Ex-dividend
- Nov 13, 2026
- Sector
- Healthcare
About Eli Lilly and Company
Eli Lilly and Company is a global medicine company focused on discovering, developing, manufacturing, and marketing human pharmaceutical products. Eli Lilly and Company operates across major therapeutic areas including diabetes, obesity, oncology, immunology, neuroscience, and cardiovascular care, serving patients, healthcare providers, and health systems worldwide. Its current portfolio includes widely used treatments for chronic metabolic conditions as well as therapies for cancer and immune-related diseases, supported by ongoing commercial operations and regulated manufacturing capacity in the United States, Europe, and Asia. The company also advances diagnostics and specialty medicines that address complex medical needs in hospital, outpatient, and community settings. Eli Lilly and Company plays a significant role in the pharmaceutical market through its broad product lineup, large-scale distribution network, and focus on prescription medicines that are used in everyday clinical practice.
Next report: Wed, Feb 3, 2027(estimated from past report dates; not yet confirmed by the company)
| Quarter | EPS estimate | EPS actual | Surprise |
|---|---|---|---|
| Oct 29, 2026(after close) | $6.35 | $7.48 | +17.8% |
| Aug 5, 2026(after close) | $6.58 | $8.38 | +27.4% |
| Apr 30, 2026(after close) | $6.79 | $8.55 | +25.9% |
| Feb 4, 2026(after close) | $6.91 | $7.54 | +9.1% |
| Oct 30, 2025(after close) | $5.89 | $7.02 | +19.2% |
| Sep 14, 2025(after close) | $0.03 | −$0.02 | −166.7% |
- Annual dividend
- $6.69
- Yield
- 0.47%
- Frequency
- Quarterly
- Next ex-date
- Nov 13, 2026
| Ex-date | Amount |
|---|---|
| Aug 14, 2026 | $1.7300 |
| May 15, 2026 | $1.7300 |
| Feb 13, 2026 | $1.7300 |
| Nov 14, 2025 | $1.5000 |
| Aug 15, 2025 | $1.5000 |
| May 16, 2025 | $1.5000 |
| Feb 14, 2025 | $1.5000 |
| Nov 15, 2024 | $1.3000 |
| Aug 15, 2024 | $1.3000 |
| May 15, 2024 | $1.3000 |
| Feb 14, 2024 | $1.3000 |
| Nov 14, 2023 | $1.1300 |
| Aug 14, 2023 | $1.1300 |
| May 12, 2023 | $1.1300 |
| Feb 14, 2023 | $1.1300 |
| Nov 14, 2022 | $0.9800 |
LLY news and filings
Loading filings…
Filings from SEC EDGAR.